We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHYF
2476
DELISTED
The Shyft Group
SHYF
| $340K | ﹤0.01% |
46,989
+14,480
| +45% | +$135K |
|
2477
Cadiz
CDZI
$275M
| $337K | ﹤0.01% |
32,701
+10,095
| +45% | +$107K |
|
2478
Teekay
TK
$981M
| $337K | ﹤0.01% |
100,752
+29,877
| +42% | +$164K |
|
2479
Southern Missouri Bancorp
SMBC
$858M
| $336K | ﹤0.01% |
9,913
+3,182
| +47% | +$111K |
|
2480
iShares S&P 100 ETF
OEF
$20.5B
| $335K | ﹤0.01% |
+3,004
| New | +$361K |
|
|
AT
2481
DELISTED
Atlantic Power Corporation
AT
| $335K | ﹤0.01% |
154,190
+45,146
| +41% | +$97.7K |
|
2482
RBB Bancorp
RBB
$455M
| $334K | ﹤0.01% |
19,009
+6,132
| +48% | +$132K |
|
|
CCXI
2483
DELISTED
ChemoCentryx, Inc.
CCXI
| $334K | ﹤0.01% |
30,596
+9,479
| +45% | +$100K |
|
|
DERM
2484
DELISTED
Dermira, Inc.
DERM
| $333K | ﹤0.01% |
46,353
+14,565
| +46% | +$159K |
|
2485
NN Inc
NNBR
$298M
| $332K | ﹤0.01% |
49,414
+21,277
| +76% | +$204K |
|
|
SPNE
2486
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $332K | ﹤0.01% |
18,193
+6,915
| +61% | +$117K |
|
2487
Distribution Solutions Group
DSGR
$1.61B
| $331K | ﹤0.01% |
20,960
+5,804
| +38% | +$90.6K |
|
|
FTSI
2488
DELISTED
FTS International, Inc. Common Stock
FTSI
| $331K | ﹤0.01% |
2,325
+839
| +56% | +$177K |
|
2489
Hurco Companies Inc
HURC
$142M
| $330K | ﹤0.01% |
9,234
+624
| +7% | +$24.9K |
|
|
BCOV
2490
DELISTED
Brightcove, Inc.
BCOV
| $330K | ﹤0.01% |
46,858
+15,468
| +49% | +$116K |
|
|
SRNE
2491
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $330K | ﹤0.01% |
137,637
+54,072
| +65% | +$177K |
|
|
NPTN
2492
DELISTED
NEOPHOTONICS CORP
NPTN
| $329K | ﹤0.01% |
50,812
+15,388
| +43% | +$118K |
|
2493
BayCom
BCML
$335M
| $328K | ﹤0.01% |
14,209
+4,542
| +47% | +$108K |
|
2494
BrightView Holdings
BV
$1.02B
| $328K | ﹤0.01% |
32,098
+11,251
| +54% | +$145K |
|
|
GNTY
2495
DELISTED
Guaranty Bancshares
GNTY
| $328K | ﹤0.01% |
12,091
+3,658
| +43% | +$99.4K |
|
2496
Toyota
TM
$222B
| $328K | ﹤0.01% |
2,826
+27
| +1% | +$3.2K |
|
|
BRG
2497
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $328K | ﹤0.01% |
36,367
+9,768
| +37% | +$90.2K |
|
|
KG
2498
Kestrel Group
KG
$69.7M
| $327K | ﹤0.01% |
9,894
+1,714
| +21% | +$92.3K |
|
2499
Alaunos Therapeutics
TCRT
$4.86M
| $327K | ﹤0.01% |
1,167
+370
| +46% | +$146K |
|
|
HK
2500
DELISTED
Halcon Resources Corporation
HK
| $327K | ﹤0.01% |
192,451
+56,694
| +42% | +$177K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.